Ferring Pharmaceuticals, founded in 1950, is a privately owned, research-driven biopharmaceutical group based in Switzerland. The company is renowned for its leadership in reproductive medicine and maternal health, with significant expertise in gastroenterology and urology. It employs over 7,000 professionals globally and operates in more than 50 countries, marketing its medicines in over 100. This extensive reach positions Ferring Pharmaceuticals as a key player in the biotechnology and pharmaceutical industries.
The company's slogan, "70 years of building families and helping people live better lives," underscores its commitment to impactful health solutions. Notably, Ferring is pioneering advancements in microbiome-based therapeutics and uro-oncology intravesical gene therapy, positioning itself at the forefront of industry innovation. Despite its robust global presence and deep industry expertise, the company has not disclosed any recent investment activities or investor affiliations, highlighting a potential area for strategic financial partnerships.